Conduit Pharmaceuticals Inc. financial data

Symbol
CDT, CDTTW on Nasdaq
Industry
Pharmaceutical Preparations
Location
4851 Tamiami Trail North, Suite 200, Naples, FL
State of incorporation
DE
Fiscal year end
December 31
Former names
Murphy Canyon Acquisition Corp. (to 9/21/2023)
Latest financial report
10-K - Q4 2024 - Mar 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 22.7 % -81.5%
Debt-to-equity -163 % -6.46%
Return On Equity 291 % +3667%
Return On Assets -462 % -4359%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.66M shares -91%
Common Stock, Shares, Outstanding 1.38M shares +87.6%
Entity Public Float 41.4M USD +78.3%
Common Stock, Value, Issued 14K USD +100%
Weighted Average Number of Shares Outstanding, Basic 867K shares +29.5%
Weighted Average Number of Shares Outstanding, Diluted 867K shares +27.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 3.38M USD
General and Administrative Expense 12M USD +133%
Operating Income (Loss) -15.4M USD -193%
Nonoperating Income (Expense) -2.38M USD -150%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.14M USD -49.1%
Income Tax Expense (Benefit) 213K USD +616%
Net Income (Loss) Attributable to Parent -17.8M USD -3227%
Earnings Per Share, Basic -20.5 USD/shares -2499%
Earnings Per Share, Diluted -20.5 USD/shares -130%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 554K USD -86.9%
Other Assets, Current 51K USD
Assets, Current 2.72M USD -52.6%
Property, Plant and Equipment, Net 40K USD
Operating Lease, Right-of-Use Asset 263K USD
Intangible Assets, Net (Excluding Goodwill) 5K USD
Assets 4.19M USD -42%
Accounts Payable, Current 1.43M USD +564%
Employee-related Liabilities, Current 40K USD -88.2%
Accrued Liabilities, Current 24.5K USD -82.3%
Liabilities, Current 10.7M USD +496%
Operating Lease, Liability, Noncurrent 107K USD
Liabilities 11M USD +43%
Accumulated Other Comprehensive Income (Loss), Net of Tax 414K USD +0.73%
Retained Earnings (Accumulated Deficit) -29.1M USD -158%
Stockholders' Equity Attributable to Parent -6.79M USD -1386%
Liabilities and Equity 4.19M USD -42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.36M USD -19.6%
Net Cash Provided by (Used in) Financing Activities 2.22M USD -98.4%
Net Cash Provided by (Used in) Investing Activities -243K USD
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 1.38M shares +87.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.38M USD -29900%
Interest Paid, Excluding Capitalized Interest, Operating Activities 80K USD
Deferred Tax Assets, Valuation Allowance 4.46M USD +207%
Deferred Tax Assets, Gross 4.46M USD +207%
Operating Lease, Liability 226K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -17.8M USD -2128%
Lessee, Operating Lease, Liability, to be Paid 253K USD
Operating Lease, Liability, Current 119K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 113K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 140K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 27K USD
Deferred Tax Assets, Operating Loss Carryforwards 2.97M USD +265%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Additional Paid in Capital 21.9M USD +110%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 10K USD
Interest Expense 100K USD 0%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%